Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 윤채옥 | - |
dc.date.accessioned | 2022-10-25T06:51:15Z | - |
dc.date.available | 2022-10-25T06:51:15Z | - |
dc.date.issued | 2021-02 | - |
dc.identifier.citation | JOURNAL OF CONTROLLED RELEASE, v. 332, Page. 285-300 | en_US |
dc.identifier.issn | 0168-3659 ; 1873-4995 | en_US |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0168365921000833?via%3Dihub | en_US |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/175799 | - |
dc.description.abstract | Adenovirus (Ad) is emerging as a promising modality for cancer gene therapy due to its ability to induce high level of therapeutic transgene expression with no risk of insertional mutagenesis, ability to be facilely produced at a high titer, and capacity to induce robust antitumor immune response. Despite these excellent attributes of human serotype 5 Ad, poor systemic administration capability, coxsackie and adenovirus receptor (CAR)dependent endocytic mechanism limiting potentially targetable cell types, nonspecific shedding to normal organs, and poor viral persistence in tumor tissues are major hindrances toward maximizing the therapeutic benefit of Ad in clinical setting. To address the abovementioned shortcomings, various non-immunogenic nanomaterials have been explored to modify Ad surface via physical or chemical interactions. In this review, we summarize the recent developments of different types of nanomaterials that had been utilized for modification of Ad and how tumor-targeted local and system delivery can be achieved with these nanocomplexes. Finally, we conclude by highlighting the key features of various nanomaterials-coated Ads and their prospects to optimize the delivery of virus. | en_US |
dc.description.sponsorship | This work was supported by grants from the National Research Foundation of Korea (2016M3A9B5942352 to C.-O. Yun) and Hanyang University General Research Grant (HY-2011-G-201100000001880). | en_US |
dc.language.iso | en | en_US |
dc.publisher | ELSEVIER | en_US |
dc.subject | Adenovirus; Viral vectors; Gene therapy; Polyethylene glycol; Bioreducible polymers; Cationic polymers; Inorganic nanoparticles; Hydrogels; Systemic administration | en_US |
dc.title | Overcoming the barriers to optimization of adenovirus delivery using biomaterials: Current status and future perspective | en_US |
dc.type | Article | en_US |
dc.relation.volume | 332 | - |
dc.identifier.doi | 10.1016/j.jconrel.2021.02.018 | en_US |
dc.relation.page | 285-300 | - |
dc.relation.journal | JOURNAL OF CONTROLLED RELEASE | - |
dc.contributor.googleauthor | Kasala, Dayananda | - |
dc.contributor.googleauthor | Hong, JinWoo | - |
dc.contributor.googleauthor | Yun, Chae-Ok | - |
dc.relation.code | 2021004235 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF ENGINEERING[S] | - |
dc.sector.department | DEPARTMENT OF BIOENGINEERING | - |
dc.identifier.pid | chaeok | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.